As the number of Americans living with Alzheimer’s disease is expected to triple by 2050, the sense of urgency for researchers to find better treatments and, ultimately, a cure for the 6 million people whose memories and lives are at stake has intensified.
The Reverse Stock Split Will Take Effect November 9, 2022 at 4:01 p.m. ET ENGLEWOOD, Colo., Nov. 8, 2022 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American/OTC Pink: AMPE), announced today that effective November 9, 2022 […]
COLORADO SPRINGS, Colo.–(BUSINESS WIRE)– #2021launchactivity–The Space Report offers a look at spending by major spacefaring nations and regional analysis of space revenue from Europe, Latin America and Africa. Click here to view original post
Pfizer is launching its second-ever rebate program, this time for Panzyga, its treatment for a rare neurological disease of the peripheral nerves. The program began last month, according to STAT which first reported the news, and […]
Copyright © 2023 Biotech Networks
